アフターアワーズ： 2.59 0.10 +4.02%

Immuneering Corp (IMRX)

Immuneering Corp (IMRX) 最新ニュース

Immuneering Corp (IMRX)

Immuneering Corp (IMRX) 最新ニュース

Immuneering Corp (IMRX)’s stock chart: A technical perspective - US Post News

Ratio Revelations: Immuneering Corp (IMRX)’s Financial Metrics in the Spotlight - The Dwinnex

Biotech Surges Premarket Following Positive Phase 2a Observations - MSN

Immuneering Corp (IMRX) Recovers 161.00% From Low: Sitting In The Catbird Seat? - Stocks Register

Immuneering Corp [IMRX] stock for 1,160,181 USD was sold by Cormorant Asset Management, LP - Knox Daily

You might want to take a look at Immuneering Corp (IMRX) now - SETE News

Immuneering Corp [IMRX] Insider Cormorant Asset Management, LP sells 400,000 Shares - Knox Daily

Inogen: Upside Seems Limited After Big Move Up (NASDAQ:INGN) - Seeking Alpha

Immune Price Drop Is An Entry Opportunity - Top Buzz Times

IMUX’s 2023 Market Saga: Unraveling the Story of Gains and Losses - The InvestChronicle

Analytical Overview: ImmunityBio Inc (IBRX)’s Ratios Tell a Financial Story - The Dwinnex

Market Momentum Report: Immunic Inc (IMUX)’s Negative Close at 1.60 - The Dwinnex

Inflection Point Acquisition Corp. II (NASDAQ:IPXX) Shares Bought by Berkley W R Corp - MarketBeat

Armored car company tires reverse domain name hijacking - Domain Name Wire

Daily Market Movement: Immuneering Corp (IMRX) Sees a -10.59 Decrease, Closing at 2.87 - The Dwinnex

IOH announces stock split to enhance investor participation - Telecompaper EN

Impax Asset Management Group (LON:IPX) Stock Passes Below Fifty Day Moving Average of $383.00 - MarketBeat

Rhumbline Advisers Acquires Shares of 67,184 Immunome, Inc. (NASDAQ:IMNM) - Defense World

ImpediMed Expands U.S. Market Coverage - TipRanks

IDP Education Reports Substantial Shareholder Changes - TipRanks

Analysts review Immunome Inc’s rating - Knox Daily

Immunome (NASDAQ:IMNM) Shares Down 5.6% After Insider Selling - MarketBeat

IMAX Co. (NYSE:IMAX) Shares Sold by Rhumbline Advisers - Defense World

Immuneering Corp Inc. (IMRX) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle

Ipsen: Parvus AM Europe Ltd falls below 5% of voting rights - Marketscreener.com

Are Immuneering Corp (IMRX) shares a good deal now? - US Post News

IPCA Laboratories Looking to Consolidate US Generics Business; Shares Gain - EquityPandit

IMI plc Advances Share Buyback with J.P. Morgan - TipRanks

Ipca Laboratories to consider consolidaton of US generics business - CNBCTV18

International Public Partnerships Buys Back Shares - TipRanks

TIFF 2024: Ick Review - keithlovesmovies.com

Integrated BioPharma (OTCMKTS:INBP) Posts Quarterly Earnings Results - Defense World

Acadian Asset Management LLC Has $61,000 Holdings in IMAX Co. (NYSE:IMAX) - Defense World

Max Rosett Sells 14,380 Shares of Immunome, Inc. (NASDAQ:IMNM) Stock - MarketBeat

ImmunityBio: Anktiva Launch, Good Data, Low Cash, High Debt (NASDAQ:IBRX) - Seeking Alpha

Immunome, Inc. (NASDAQ:IMNM) CFO Max Rosett Sells 14,380 Shares - Defense World

Immunome CFO sells shares valued at over $230,000 By Investing.com - Investing.com Canada

Immunome CFO sells shares valued at over $230,000 - Investing.com

Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024 - StockTitan

Ick Review — TIFF 2024 - CGMagazine

IMI (LON:IMI) Stock Passes Above Two Hundred Day Moving Average of $1,805.79 - Defense World

Indofarma Corruption Case Rp371 Billion, Former President Director Allegedly Buys Fictitious Medical Devices - VOI.ID

Staff Of Erick Thohir Regarding Ex-Director Of Indofarma Becomes A Suspect: Part Of Cleaning Up SOEs - VOI.ID

State Loss Of IDR 371 Billion, DKI Prosecutor's Office Explains The Role Of Three Corruption Suspects Of PT Indofarma - VOI English

why ImmunityBio Inc [IBRX] is a Good Choice for Investors After New Price Target of $6.38 - The DBT News

Immunome (NASDAQ:IMNM) Sees Strong Trading Volume - MarketBeat

Primecap Management Co. CA Purchases 55,800 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World

Former President Director Of PT Indofarma Tbk Becomes A Corruption Suspect Who Loses Rp371 Billion To The State - VOI.ID

Immuneering Corp [IMRX] Shares Fall Approximately -71.25% Over the Year - Knox Daily

ImmunityBio, Inc. (NASDAQ:IBRX) Shares Purchased by Private Advisor Group LLC - Defense World

IMNM Stock Sees Surge of Approximately 7.19% in Last Five Days - Knox Daily

Chardan Capital Brokers Lift Earnings Estimates for Immuneering Co. (NASDAQ:IMRX) - MarketBeat

360 ONE WAM boards OKs raising funds up to Rs 2,250 crore via QIP route - Business Standard

Iltani expedites antimony, silver hunt via $2.1 million capital raising - Mining.com.au

Imagion Biosystems Issues New Equity Securities - TipRanks

Sealed Air Corp. [SEE] Investment Guide: What You Need to Know - Knox Daily

Ick (2024) - Screen Rant

Ick Cast & Director Explain Why The Film Is Meant To Be Watched In Its Classic Form [TIFF] - Screen Rant

IMI plc Executes Share Buyback Program - TipRanks

Imerys: up sharply after positive analysis - Marketscreener.com

Gaining Ground: Immunome Inc (IMNM) Closes Lower at 15.40, Down -2.47 - The Dwinnex

Investors in cash trouble should check out IO Biotech Inc (IOBT) - SETE News

IBRX Stock on the Rise: A Promising Investment - The InvestChronicle

Market Watch: Immuneering Corp (IMRX)’s Noteworthy Drop, Closing at 2.78 - The Dwinnex

Integrated Industries Ltd Reports 462 per cent Net Sales Growth and 225% Profit Increase; Stock Split Record Date Set for Oct 1 - ANI News

3 Penny Stocks to Watch Now, 9/18/24 - TipRanks

IO Biotech (NASDAQ:IOBT) PT Raised to $6.00 - Defense World

Needham Initiates Coverage of Immuneering Corp (IMRX) with Buy Recommendation - MSN

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 - Tech Funding News

Immunome (NASDAQ:IMNM) Shares Down 3.3% - MarketBeat

Evaluating the Relationship Between Immuneering Corp Inc. (IMRX) Price Performance and Dividends - The InvestChronicle

Earnings call: ImmunoPrecise announces mixed Q1 results, eyes future growth - Investing.com

ImmunOs Therapeutics AG raises US$11m in Series C financing - European Biotechnology News

IP Group on a steep discount but rewards investors with buyback - Investors Chronicle

ImmunOs Therapeutics Raises $11M in Series C Funding - FinSMEs

Post-Trade Analysis: ImmunoPrecise Antibodies Ltd (IPA) Slides -19.12, Closing at 0.54 - The Dwinnex

Innovation Driving Cancer's Solid Tumors Market - StockTitan

Immunic (NASDAQ:IMUX) Raised to Strong-Buy at EF Hutton Acquisition Co. I - MarketBeat